Delivery Order SPE2DB25D3504-SPE2DB25FVWGH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,959.19 to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 40 mg tablets (500 count) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreements with the agency. The product will be delivered to the company's facility in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,329.50 to AmerisourceBergen Drug Corp for the supply of Citalopram HBR 40 mg tablets (500 count) on September 9, 2025, with an ultimate completion date of September 10, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and identifies the place of performance as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 40 mg tablets (500 count) valued at $33,841.22 under a firm fixed-price contract type. The award was made on July 23, 2025, with an ultimate completion date of July 24, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania serves as the place of performance for this delivery order. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Citalopram HBR 40 mg tablets (500-count units) with a ceiling value of $12,406.14. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $17,210.57 to AmerisourceBergen Drug Corp for the supply of Citalopram HBR 40 mg tablets (500 count) on September 11, 2025, with an ultimate completion date of September 12, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Citalopram HBr 10 mg tablets (500 count) with a ceiling value of $10,708.82. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order is scheduled for completion by July 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $16,451.57 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of 500 tablets of Citalopram HBR 40 mg, with completion expected by September 5, 2025. This competitively awarded contract utilizes firm fixed-price pricing and carries no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Citalopram HBr 40 mg tablets in quantities of 500 units, with a ceiling value of $6,023.38. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for ultimate completion by September 3, 2025, and will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,023.19 to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 20 mg tablets (500 tablets) on September 8, 2025, with an ultimate completion date of September 9, 2025. This contract utilizes a firm fixed price structure with no set-aside designation, indicating competitive award through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Citalopram HBR 40 mg tablets (500 count) valued at $3,705.96. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of August 4, 2025. The performance location is AmerisourceBergen Drug Corp's corporate office in Conshohocken, Pennsylvania. Citalopram is a selective serotonin reuptake inhibitor...
- SPE2DB25D3504Indefinite Delivery Contract
- SPE2DB25D3504-SPE2DB25FVWGHDelivery Order
The Defense Logistics Agency awarded a $2,247.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 40 mg tablets (100 count) on September 9, 2025, with completion scheduled for September 10, 2025. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The award was made without set-aside designation through competitive procurement, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical supply requirements. Performance will occur at the company's corporate office in Conshohocken, Pennsylvania. This transaction exemplifies the Defense Logistics Agency's pharmaceutical procurement strategy, which leverages prime vendor contracts to ensure consistent supply of essential medications to military and veteran healthcare systems. AmerisourceBergen, as a major pharmaceutical distributor, fulfills a critical role in supporting the Defense Health Agency and other government healthcare entities by delivering both brand-name and generic medications across multiple therapeutic domains. The citalopram order falls within the company's extensive portfolio of psychiatric and neurological treatments distributed through the DLA Medical Supply Chain, supporting mental health care across the Department of Defense healthcare network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 9/9/25 |